Nikoletta Sidiropoulos, MD describes the importance of institutional support to ensure equitable access to biomarker testing to improve cancer patient care. Nikoletta Sidiropoulos is an associate professor at the Department of Pathology and Laboratory Medicine, University of Vermont Medical Center. Learn about insourcing NGS: youtu.be/eaAJ2zqm1uc Subscribe to the Illumina video channel youtube.com/subscription_center?add_user=IlluminaInc A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond. View customer spotlight videos youtube.com/playlist?list=PLKRu7cmBQlajfheLzgbI4S7xBn7IDbt79 View Illumina webinars youtube.com/playlist?list=PLKRu7cmBQlahpXlnrrXlQw9itVJ8yHwUZ View Illumina support videos youtube.com/playlist?list=PLKRu7cmBQlajbm2KGsICWb-JOnusJfYvM LinkedIn: linkedin.com/company/illumina X: x.com/illumina Instagram: instagram.com/illuminainc Facebook: facebook.com/illuminainc TikTok: tiktok.com/@illuminainc #Illumina #NGS #biomarker #PrecisionMedicine